Psychedelic Spotlight Podcast

This week on the Psychedelic Spotlight podcast, we talk with Sam Chapman. Sam is a resident of Portland, Oregon, he was the Campaign Manager for Oregon Measure 109, and is now the Executive Director of the Healing Advocacy Fund, a nonprofit organization dedicated to supporting the nation’s first regulated psilocybin therapy program. This episode takes an interesting look at how Oregon plans to expand access and equity for their psychedelic assisted-therapy services, which Oregon voters passed in 2020. We also hear Sam’s thoughts on other states' psychedelic policies, and he provides advice for people who want to get involved in drug legislature in their cities and states. Lastly, he gives insight into the future of the psychedelic field and what he hopes to see in terms of psychedelic legalization, decriminalization, and education. To learn more and connect, please visit https://healingadvocacyfund.org/ and check out https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/Pages/Oregon-Psilocybin-Services.aspx to stay up to date on Oregon Measure 109’s progress.

This week on the Psychedelic Spotlight podcast, we provide a recap of the inaugural Benzinga Psychedelic Capital Conference which took place in Fontainebleau Miami Beach on April 19, 2022. This conference was the gathering of major psychedelics industry leaders and investors, and our Director of Video Production Matthew Dunehoo had the opportunity to attend and touch base with industry movers and shakers Daniel Carcillo from Wesana Health, Natalie Ginsberg from MAPS, Olivia Mannix from Felicity Pharma, and Klee Irwin from Irwin Naturals. For more information on the Benzinga Psychedelic Capital Conference, visit https://www.benzinga.com/events/psychedelics/

Lana Rados is a holistic psychotherapist with almost 40 years of clinical and professorial teaching experience. Formally trained in clinical psychology, Lana is most notable for her work in trauma and relational therapy. Her rich and intuitive understanding of the human psyche has enabled her to create a unique and highly effective modality of psychological healing. With her husband, Ivan Rados, an internationally renowned spiritual teacher, healer and author, Lana has co-founded Intronaut, which facilitates plant medicine ceremonies and retreats in Vancouver, Canada. To date, Intronaut has led hundreds of individuals through some of the most transformational experiences of their lives. In today's episode, Lana describes her journey from being a clinically-focused empiricist to eventually opening up to the possibilities of mystical states of consciousness, discusses how plant medicine can be effective for healing all levels of trauma, and updates us on her view of the clinical and spiritual perspectives of psychedelic-assisted psychotherapy. *You can find out more about Lana Rados and her work with Intronaut at https://www.intronaut.com/

This week on the Psychedelic Spotlight podcast, we're chatting with Dr. Erica Zelfand. She is a family doctor specializing in integrative and functional family medicine. She’s also a ketamine prescriber, facilitator of therapeutic experiences, and a medical writer and public speaker. This episode takes an interesting look at the topics of psychedelic-assisted therapy and holistic modalities through the lens of a licensed physician, where Dr.Erica discusses how the comprehensive use of both natural and prescribed medicine can work to effectively heal an individual overall. She also touches on some of the limitations of both natural and pharmaceutical medicine for mental health treatments, and how her diverse experience in the holistic and medical community has contributed to her versatile understanding of the connection between the mind, body and spirit. To learn more and connect, please visit www.DrZelfand.com, and check out her CE- and CME-approved online course on psychedelics at ScienceofPsychedelics.com. For a 20% discount on Dr.Erica Zelfand’s course, use the code PSYCspotlight upon checking out!

On the Psychedelic Spotlight podcast this week, we're excited to have Joe Moore. He is the Founder and CEO of Psychedelics Today, one of the leading psychedelic education platforms in the space.In this episode, Joe discusses some of his background and his journey into psychedelics, the current landscape of the industry and his thoughts on its general direction, and some topics that get him going, including legislation and reform, drug exceptionalism, and why we need to defund the DEA to really progress the movement overall. He also shares his thoughts on the future and what we might have to look forward to as psychedelics continue down the trajectory of decriminalization and possibly legalization.*Psychedelics Today has just launched a holistic, immersive 12-month certificate training program for professionals to master the elements of psychedelic-informed therapy and integration, beginning April 2022.Designed by trusted education leaders Psychedelics Today and taught by over 30 industry pioneers in a digital environment, Vital bridges academic, clinical, philosophical, and reflective approaches to healing.The program features experiential retreats and offers flexible payment plans with diversity and equity scholarships available. No prerequisites are required.Applications are open until March 27. Visit vitalpsychedelictraining.com for more information or to apply.

In this episode of the Psychedelic Spotlight podcast, Swati sits down with leaders from Kaivalya Kollectiv, “a multifaceted company focusing on psychedelic wellness, education", and more. She speaks with Victoria Wueshner, a 5-MeO-DMT Facilitator and the Founder of FIVE, and Joël Brierre, CEO of Kaivalya Kollectiv. Kaivalya Kollectiv aims to combine ancient Eastern and Indigenous practices with modern science and Western therapies.Kaivalya’s motto is “ancient roots for modern growth”. Their flagship resorts, titled Tandava Retreats, are an immersive, world-class retreat center in Tepoztlan, Mexico, working with 5-MeO-DMT in a safe and effective container that utilizes philosophies and techniques of the ancient mystery schools and supports them with a modern Western approach. Before the interview, Swati went through a ceremony at Tandava Retreats, and experienced the psychedelic 5-MeO-DMT. She then experienced the integration period with the assistance of Joël and Victoria. In the discussion, Victoria and Joël discuss how to prepare for a ceremony, the nuances of the 5MeO-DMT experience and industry, and how to integrate the experience afterward. They also talk about who can benefit the most from a 5-MeO-DMT experience, and who it's best not suited for. Kaivalya Kollectiv considers 5-MeO-DMT to be a powerful and sacred medicine, and believes that its intentional use can help many individuals. You can learn more about Kaivalya Kollectiv and Tandava Retreats here: TandavaRetreats.com Enjoy the interview!

Over the last several decades, Rick Doblin and his organization, MAPS, have been at the forefront of changing cultural attitudes surrounding psychedelics. They have accomplished this through several avenues. The first is researching the medical applications of psychedelics. Most prominently, they have been testing treating severe PTSD with MDMA-assisted therapy, the results of which have been amazing. For example, in their most recent phase 3 clinical trial, 67% of patients with severe PTSD improved so much they no longer qualified for the diagnosis of PTSD. In this interview, James and Rick discuss this trial and upcoming follow-up trials.MAPS has also been involved in extensive psychedelic education campaigns. Their newest endeavor is a “psychonaut training program”, which will teach regular people how to “trip” properly, and how to be a trip sitter.Finally, James and Rick discuss his wild plan in the 80s to send MDMA to the Soviet Union in an attempt to make nuclear negotiators more empathetic. Join us on this amazing journey.

In today's episode of the Psychedelic Spotlight Podcast, James Hallifax sits down with James Lanthier, CEO of Mindset Pharma. Mindset Pharma is a psychedelic medicines company that is working on next-generation psychedelic compounds that are inspired by psilocybin and DMT/ 5-MEO-DMT. The company plans on creating medicines to be used for both psychedelic therapy, and microdoses. On January 5th, Mindset announced that they have partnered with the Japanese pharmaceuticals company Otsuka, to help them develop several new psychedelic medicines. In this conversation, the two James' discuss all of this and more, getting to the bottom of Mindset's philosophies and business strategy.You can find Mindset Pharma trading on the Canadian Securities Exchange under the symbol $MSET and on the American OTC market under the symbol $MSSTF. *To learn more about Mindset Pharma visit their website: MindsetPharma.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

In this episode of the Psychedelic Spotlight podcast, Psychedelic Investor, James Hallifax interviews Matt Stang, Co-Founder and CEO of Delic Corp. Delic is a psychedelic medicines company focused on bringing psychedelic wellness to the mainstream through their infrastructure of ketamine therapy clinics; the largest in the U.S.You can find Delic Corp trading on the Canadian Securities Exchange under the symbol $DELC and on the American OTC market under the symbol $DELCF. *To learn more about Delic, visit their website: DelicCorp.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

This week, we spent some time chatting with Julianne Keu. She is a YouTube content creator with one of the fastest-growing channels in the psychedelics niche. She’s a powerful advocate for the use of psychoactive plants and their use in treating challenging mental health conditions. Julianne is also an apprentice healer at Intronaut, where she is training with facilitators of various modalities of plant medicine healing in hopes of one day becoming a facilitator herself. In this episode, Julianne describes how she used microdosing to help aid in the treatment of her mental health challenges during the pandemic, how she began macrodosing with psilocybin to address deeper-rooted traumas, how participating in shamanic ceremonies have led her to explore the spiritual and mystical world, and much more.*To learn more about Julianne, visit: JulianneKeu.com*Pre-order your Wakeful Travel Psychedelic Integration Journal HERE!*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

This week, we had the opportunity to chat with Ed Prideaux. He is a UK-based writer and journalist who has lived with the symptoms of Hallucinogen Persisting Perception Disorder (HPPD) since he was a teenager. An enthusiast of psychedelic experience and its clinical promise, Prideaux seeks to bridge HPPD patient groups with the psychedelic community through advocacy for the Perception Restoration Foundation, a 501 (c) (3) charity that raises awareness and funds for studies into HPPD and Visual Snow Syndrome. He has written about psychedelics for the BBC, VICE, and The Independent, and has been featured in publications such as The Guardian, The Spectator, The Financial Times, and more.In this chat, Ed outlines how his own experiences with HPPD have led him to investigating the illness further, his work with the Perception Restoration Foundation and the organization’s efforts at researching methods in psychedelic harm reduction, and his thoughts on the current landscape of the medicinal psychedelic industry and its inevitable challenges to the public as things move forward. *To read some of Ed Prideaux’s work, head to EdPrideaux.journoportfolio.com*Only 3 more days to donate to Wakeful Travel’s Kickstarter! Click *here* to get your integration journal today! *Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

In this episode, James Hallifax from the Psychedelic Investor, interviews Doug Drysdale, CEO of Cybin (NYSE: CYBN). In this fantastic discussion, Doug and James discuss the potential for psilocybin (magic mushrooms) to treat depression and other mental health issues. The conversation then pivots to what Cybin sees as the main issues with psilocybin: its long duration of effect, long period before onset action, and the variability in effects from person to person.*Learn more about Cybin by visiting their website: Cybin.com*Pre-order your Wakeful Travel Psychedelic Integration Journal HERE!*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

In this episode, Sena Maria gives us an overview of her Microdosing Activation program and explains some of the benefits of microdosing.*To learn more about Sena Maria and microdosing, visit: MicrodosingForResilience.com*Pre-order your Wakeful Travel Psychedelic Integration Journal HERE!*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

This week, we have the pleasure of speaking with Sa’ad Shah, Managing Partner for Noetic Fund. Noetic Fund is a venture capital fund focused on psychedelic medicine and related sustainable solutions for mental health and physical well being. In our conversation, Sa’ad gives us an overview of how his interest in philosophy led to his involvement with plant medicine, how the psychedelic industry is currently misunderstood and under appreciated, Noetic's portfolio selection process, and more!*You can learn more about Sa'ad and Noetic Fund by visiting their website: NoeticFund.com*Pre-order your Wakeful Travel Psychedelic Integration Journal HERE!*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

This week, we took some time to chat with health coach, Awais Spall. He is a Functional Diagnostic Nutrition Practitioner and researcher using functional medicine, Ayurveda, biohacking and entheogens in his practice. His company, Integrative Oasis, aims to help heal individuals suffering with gut-related health challenges and restore their wellbeing through natural medicinal practices.In this conversation, we discuss some critical points such as how he managed to heal himself through the use of Ayurveda and functional medicine which led him down the path to working with these interesting modalities, how ancestral healing has the ability to significantly influence an individual's wellbeing overall, how his practice uses entheogens to cure physical ailments such as Traumatic Brain Injury, and more! *To learn more about Awais and Integrative Oasis, visit their website: IntegrativeOasis.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

In this episode of the Psychedelic Spotlight podcast, we catch up with psychedelic feminist Zoe Helene. She is an artist, environmentalist, and cultural activist best known for women's empowerment and working with sacred psychedelic plants and fungi. She is the founder of Cosmic Sister, an environmental feminist collective advocating for the widespread education of psychedelic feminism and women-centered visibility in the space.In our conversation, we discuss some of Zoe’s formative experiences in the creative arts which led her down the path of plant medicine advocacy, core feminist issues and how psychedelics play a role in furthering women’s movements, why an emphasis on equity and representation within the budding psychedelic industry is crucial and still has a long way to go, and so much more.*To learn more about Zoe and Cosmic Sister, visit the website: ZoeHelene.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

This week, we sat down with Patrick Moher from Microdose to discuss his work cultivating Wonderland Miami, the biggest psychedelic conference in the industry. Patrick’s work focuses on helping companies combine creativity, CSR, and sustainable profits while uniting individuals across social and corporate spectrums to create unique business solutions. In this chat, he discusses some of the challenges involved in moving virtual events to an in-person conference (during a pandemic), who and what to expect at the event, and why Wonderland Miami is not just any other conference, but a one-of-a-kind experience. *Visit Microdose.buzz and use the promo code 'PsychedelicSpotlight' for 20% off any ticket to Wonderland, Miami (taking place November 8th to 9th).*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

Today on the Psychedelic Spotlight podcast, we speak with Joseph Mays. He is an ethnobotanist, researcher, and the Program Director of Chacruna's Indigenous Reciprocity Initiative. Here, he conducts research and builds connections with small Indigenous communities throughout the Americas to support Chacruna’s mission of increasing cultural reciprocity in the psychedelic space.In our conversation with Joseph, we chat a bit about some critical topics such as how psychedelics can allow us to understand the Indigenous philosophy of interrelatedness between one another and our ecosystems, the importance of considering sacred reciprocity to Indigenous peoples and their land, and how Chacruna's Indigenous Reciprocity Initiative is making it simple for companies to give back to the societies who have cultivated psychedelic medicine.*To learn more about Chacruna, visit their website: Chacruna.net*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

In this episode of the Psychedelic Spotlight podcast we chat with James Lanthier, CEO of Mindset Pharma, a Toronto based drug discovery company focused on creating novel and patentable psychedelic compounds for the treatment of neurological and psychiatric disorders. You can find Mindset Pharma trading on the Canadian Securities Exchange under the symbol $MSET and on the American OTC Markets under the symbol $MSSTF.In our conversation, James goes into detail about Mindset’s new lead drug candidate MSP-1014, when the company expects to take the drug to clinical trials, and why next generation drugs are an important commercial opportunity for anyone looking to invest in the psychedelic sector.*To learn more about Mindset Pharma, visit their website: MindsetPharma.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

In today’s episode of the Psychedelic Spotlight podcast, the Psychedelic Investor, James Hallifax interviews Ian McDonald, CEO and Director of Bright Minds Biosciences. For any investors out there, you can find Bright Minds Biosciences trading on the Canadian Securities Exchange under the symbol $DRUG and on the American OTC market under the symbol $BMBIF. In this wide ranging interview many topics are covered, starting with the philosophy and vision of Bright Minds. We discuss most of Bright Minds’ major projects, including using new psychedelic medicines to treat chronic pain. This is exciting, since it could not only help people with chronic pain issues such as fibromyalgia, but it could also put a dent in the opioid use crisis by preventing people from being prescribed opioids by their doctors to treat pain. Bright Minds is a company working on second and third generation psychedelics to treat a variety of ailments including depression, PTSD, epilepsy, addiction and more. The driving philosophy is that while classic psychedelics such as psilocybin and LSD do show great potential to be used in a therapy setting to treat mental health issues, the compounds also have limitations. At Bright Minds, the goal is to engineer completely new compounds, often based on the structure of classical psychedelics, that keep the benefits of said drugs while doing away with potential negatives. Important to note is that while psychedelic derived drugs are a focus of the company, they also are creating non-psychedelic compounds for a variety of ailments, including different forms of addiction. *To learn more about Bright Minds Biosciences, visit their website: BrightMindsBio.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

In this episode of the Psychedelic Spotlight podcast, we speak with Trevor Millar, a distinguished Advisor to NeonMind Biosciences, an integrated drug development and wellness company focused on the potential therapeutic uses of psilocybin for treating obesity and weight management conditions. In our conversation with Trevor, we have the opportunity to discuss some of the psychedelic-based treatments NeonMind is currently focused on developing to help tackle this very serious health condition. Obesity is one of the more prevalent health conditions today affecting millions of individuals worldwide. The World Health Organization has claimed that obesity has reached epidemic proportions globally with at least 2.8 million people dying each year as a result of being overweight or obese. *You can find NeonMind Biosciences trading on the Canadian securities exchange under the symbol $NEON. To learn more about the company, visit their website: NeonMindBiosciences.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.com

Today on the Psychedelic Spotlight podcast, we speak with Matt Zemon who is the Co-Founder and Chief Strategy Officer for Psychable, an online community connecting people who are exploring (or would like to explore) the power of psychedelic-assisted therapy with practitioners who can support them.In our conversation with Matt, we tackle a variety of extremely important and highly-relevant subject matters such as how technology can be utilized to enhance the community of psychedelic healing, conscious capitalism, corporate responsibility, and how companies like Psychable are willing to go out of their way to connect with investors who are motivated not only by profit, but a company’s ability to contribute to the greater good of humanity.*To find out more about Psychable, visit their website: Psychable.com*Learn about the North Star Ethics Pledge*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight

In today’s episode of the Psychedelic Spotlight podcast, we sit down with Doug Drysdale, CEO of Cybin, a biotechnology company focused on creating new, effective, and accessible psychedelic-based therapies.In our conversation, Doug talks about the company’s mission to revolutionize mental healthcare, how Cybin is delivering powerful and effective therapies, and why being the first psychedelic-based company to list on the New York Stock Exchange was a natural fit. Cybin can be found on the NYSE under the ticker symbol $CYBN.*To learn more about Cybin and the work they’re doing, visit their website: Cybin.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight*This interview was recorded on September 2, 2021.

In this episode of the Psychedelic Spotlight podcast, we chat with Michelle Janikian. Michelle is a journalist, author, editor and co-host at Psychedelics Today. She has been a columnist and writer focused on cannabis and psychedelics at Playboy, and has featured her work in Rolling Stone, High Times Magazine, DoubleBlind Mag, the Huffington Post blog and more. Michelle opens up about how her work as a cannabis writer led her down the path of psychedelics, her interest in safe magic mushroom use and why she was compelled to write her guidebook Your Psilocybin Mushroom Companion. As a powerful advocate for the healing effects of psychoactive plants, her book, Your Psilocybin Mushroom Companion outlines all that you need to know about sacred mushrooms.To find more of Michelle's work, visit her website: MichelleJanikian.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight*This interview was recorded on August 17, 2021.

On the show this week we have Steven Huang, Diversity, Equity, and Inclusion consultant at MAPS and Numinus. His consultancy company, Millennial HR Design, focuses on the intersection of DEI and psychedelics, where he intends to be a leverage point for the psychedelics industry to better understand their impact on marginalized communities. With nearly 10 years of industry experience, Steven hopes for more diverse and equitable representation in the psychedelic space. In this episode, Steven discusses how he found his way into the DEI area and why psychedelics caught his interest, why "identity" is so powerful and should be considered when hiring within the psychedelic industry, common issues that people of colour experience regarding access to psychedelic-assisted psychotherapy, and so much more.You can find more of Steven's work in this area at the following link: www.millennialHRdesign.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight*This interview was recorded on August 9, 2021.

In today's episode of the Psychedelic Spotlight podcast, we spotlight Chris Kilham, Founder of Medicine Hunter Inc. Chris works alongside companies to develop plant-based food and medicinal products, helping turn them into market successes. He has conducted medicinal plant research and sustainable botanical sourcing in over 45 countries, and has been featured on a number of platforms such as The New York Times, The Dr. Oz Show, Business Insider, CNN, VICE, and much more. In our conversation with Chris, we learn about his experiences in Peru, researching the sustainability and ceremonial utilization of ayahuasca. Chris also shares his experiences investigating the power of medicinal and psychoactive plants and their healing properties.*For more information about Chris Kilham and Medicine Hunter, visit: MedicineHunter.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight*This interview was recorded on July 29, 2021.

In this episode of the Psychedelic Spotlight podcast, we spotlight Evan Levine, Chairman & CEO of PsyBio Therapeutics, an intellectual property driven biotechnology company developing novel formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health issues and other disorders.In our conversation with Evan, we get the opportunity to learn more about the unique therapeutic solutions PsyBio is currently focused on developing, and we gain a more concise understanding of the value the company is establishing for itself through its evolving intellectual property portfolio of biosynthetic psychoactive compounds.*To learn more about PsyBio Therapeutics and the work they’re doing, visit their website: PsyBioLife.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight*This interview was recorded on August 10, 2021.

In today’s episode of the Psychedelic Spotlight podcast, we spotlight Henri Sant-Cassia, Co-Founding Partner of The Conscious Fund, a leading investment fund in the medicinal psychedelics industry, focused on early stage ventures and psychedelic medicine that are helping to deliver better outcomes for mental health, addiction and pain.In our conversation, Henri provides us with some key updates of the Fund’s progress during the second quarter of the year, and shares his thoughts on companies from the Fund’s portfolio making their way to some of the more prominent stock exchanges.*To learn more about The Conscious Fund and the work they’re doing, visit their website: theconscious.fund*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight*This interview was recorded on August 10, 2021.

In today’s episode of the Psychedelic Spotlight podcast, we feature Laura Dawn. Laura Dawn is a microdosing mentor, visionary life coach, business consultant, author, international speaker, and host of the Psychedelic Leadership podcast.In our conversation with Laura Dawn, we discuss how she inspires others to embody heart-centered leadership to influence real-world change, and how sacred plant medicine has assisted her with foraging an authentic path for her life's work. *To learn more about Laura Dawn and to listen to The Psychedelic Leadership podcast, visit: LiveFreeLauraD.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight*This interview was recorded on July 27, 2021.

In today’s episode of the Psychedelic Spotlight podcast, we spotlight Dimensions Health Centers who are creating a new paradigm for hospitality by helping people to improve and transform their lives by drawing on the restorative power of nature, spa rituals, delicious food, and psilocybin-inspired ceremonies in safe, legal and luxurious settings.In our conversation, Co-Founder and CEO, Christopher Dawson along with Co-Founder and COO, Andrew Galloway, share details with us about Dimensions, and how the company plans to incorporate psychedelic-assisted healing into the business model for their one of a kind retreats.*To learn more about the company discussed in this episode and the work they’re doing, visit their website: DimensionsHealing.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight*This interview was recorded on June 30, 2021.

In the latest episode of the Psychedelic Spotlight podcast, we speak with Spencer Hawkswell who is the CEO of TheraPsil, a non-profit coalition of healthcare professionals, patients, and advocates dedicated to obtaining legal access to psilocybin-assisted psychotherapy for Canadians in medical need.In our conversation with Spencer, we discuss the different challenges he and the TheraPsil team are focused on overcoming to increase access to psilocybin-assisted psychotherapy for patients in Canada suffering through end-of-life distress, and why psilocybin, in particular, is capable of offering certain patients relief from their suffering.*To learn more about the company discussed in this episode and the work they’re doing, visit their website: TheraPsil.ca*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight*This interview was recorded on July 20, 2021.

In this episode of the Psychedelic Spotlight podcast, we feature James Hallifax, Co-Founder of The Psychedelic Investor, an emerging media company covering the medicinal psychedelics space and partner of Psychedelic Spotlight. In our conversation with James, we talk about what led him to launching The Psychedelic Investor, the potential he sees in the medicinal psychedelics industry, and what companies within this space he is currently paying close attention to and why. *Make sure you subscribe to The Psychedelic Investor on YouTube and visit their site at: ThePsychedelicInvestor.com*Subscribe to our newsletter to get the latest industry news around all things psychedelics: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight *This interview was recorded on July 14, 2021.

In this episode of the Psychedelic Spotlight podcast, we feature Jemie Sae Koo, CEO and Founder of Psychable, a comprehensive online platform legally connecting individuals to psychedelic healthcare practitioners.In our conversation, Jemie opens up about her personal experience using ayahuasca, why psychedelic assisted therapy is important amid the current mental health crisis, and the various resources Psychable has to offer.*To learn more about the company featured in this episode and the work they’re doing, visit their website: Psychable.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on July 16, 2021.

In this episode of the Psychedelic Spotlight podcast we catch up with Daniel Carcillo, Founder and CEO of Wesana Health, to talk about the company's recent listing on the CSE, their plans to uplist to the NASDAQ, and their recently formed partnership with the University of South Carolina and what it means for the development of more effective treatments for TBI. *To learn more about the company featured in this episode and the work they’re doing, visit their website: WesanaHealth.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on July 7, 2021.

In this episode of the Psychedelic Spotlight podcast, we feature Anthony Tennyson, CEO of Awakn Life Sciences, a biotechnology company with clinical operations developing and delivering psychedelic medicine to treat addiction.In our conversation with Anthony, we gain insight on Awakn's psychedelic therapy delivery activities, the company's plans to expand across the EU, and what the addition of renowned neuroscientist, Professor David Nutt as their Chief Research Officer means to their ongoing growth initiatives.*To learn more about the company featured in this episode and the work they’re doing, visit their website: AwaknLifeSciences.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on June 30, 2021.

In this episode of the Psychedelic Spotlight podcast, we spend some time with Tesla La Touche who is the Founder and CEO of Aphrodite Health, the first ever female-founded biotech company within the medicinal psychedelic industry. In our conversation with Tesla we discuss the many shortcomings of effective treatment options associated with various women's health conditions, as well as how Aphrodite is focused on developing targeted psychedelic medicines that they hope will more effectively address these conditions while simultaneously building a value-driven company within the emerging psychedelic industry. *To learn more about the company featured in this episode and the work they’re doing, visit their website: Aphrodite.Health*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on June 15, 2021.

In this episode of the Psychedelic Spotlight podcast we speak with Lauren Taus who is the Founder of INBodied Life, who's focus is on integrating modern science and ancient wisdom to support transformation.In our conversation with Lauren, we discuss the growing community of psychedelic healing, how the global and social events over the past year have contributed to the rising cases of depression and anxiety, and why it is important for individuals in and from positions of privilege to lift up others within society.*To learn more about the company featured in this episode and the work they’re doing, visit their website: INBodiedLife.com or PsychedelicCoalitionforHealth.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on May 28, 2021.

In this episode of the Psychedelic Spotlight podcast, we welcome back Nick Levich for our "Ask a Psychedelic Professional" series and as part of our "Ask a Psychedelic Guide" episode.As the Co-Founder and Facilitator of Psychedelic Passage, we tap into Nick's knowledge and expertise as a Psychedelic Guide and present him with a list of fascinating questions presented by our followers as it relates to the role, responsibility, and purpose of a Psychedelic Guide.*To learn more about the company featured in this episode and the work they’re doing, visit their website: PsychedelicPassage.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on June 2, 2021.

In this episode of the Psychedelic Spotlight podcast, we speak with Rebecca Martinez and Elan Hagens who are the Founders of Fruiting Bodies Collective, a mission-based resource hub and online platform serving the growing psychedelic healing community. In our conversation with Rebecca and Elan, we discuss how Fruiting Bodies is playing an integral role in helping to develop educational resources that will encourage, inspire, and promote inclusivity for people of color and those from marginalized communities as psychedelic-assisted healing becomes more prevalent throughout society. We also discuss their efforts as it relates to the rollout of the psilocybin-assisted therapy program in the state of Oregon. *To learn more about the company featured in this episode and the work they’re doing, visit their website: FruitingBodiesCollective.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on May 18, 2021.

In this episode of the Psychedelic Spotlight podcast, we speak with Charlotte James and Undrea “Dre” Wright of The Ancestor Project, who's mission is to "integrate ancestral Sacred Earth Medicine wisdom into the modern journeyers’ experience to reduce harm and expand consciousness." We discuss the origins of the project, the impacts they're having on their communities and how that aligns with healing in the Black community over the last year.*To learn more about the company featured in this episode and the work they’re doing, visit their website: TheAncestorProject.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on May 12, 2021.

In this episode of the Psychedelic Spotlight podcast, we speak with Dr. Ingmar Gorman who is the Co-Founder and Lead Trainer at Fluence, and a Principal Investigator for the Multidisciplinary Association for Psychedelic Studies ("MAPS").In our conversation with Dr. Gorman, we learn about the educational and training resources Fluence is focused on developing to address the growing interest in psychedelic integration and psychedelic-assisted psychotherapy. Dr. Gorman is also kind enough to share his expertise and perspective as it relates to the encouraging results recently released surrounding the Phase 3 Trials testing MDMA-assisted psychotherapy for PTSD conducted by MAPS, and what it potentially means for the future of MDMA-assisted psychotherapy.*To learn more about the company featured in this episode and the work they’re doing, visit their website: FluenceTraining.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on May 19, 2021.

In this episode of the Psychedelic Spotlight podcast, we speak with David Champion who is the Co-Founder and CEO of Maya Health, a company dedicated to empowering psychedelic practitioners with the technology and insight they need to scale psychedelic healthcare safely and effectively.In our conversation with David, we learn how Maya Health is leveraging data and analytics to develop an interconnected ecosystem designed to inspire a more streamlined process for the growing number of therapists and practitioners throughout an expanding psychedelic community. *To learn more about the company featured in this episode and the work they’re doing, visit their website: MayaHealth.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on May 12, 2021.

In this episode of the Psychedelic Spotlight podcast, we spend some time with Timothy Ko who is the CEO of Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) (FSE: “1XU1”) a biotechnology company focused on developing psychedelic medicines to treat addiction.In our conversation with Mr. Ko, we discuss how the company plans to utilize the psychedelic compound, DMT, to address the global addiction crisis, and how they are using genetics to develop more effective personalized treatment regimens for patients.*To learn more about the company featured in this episode and the work they’re doing, visit their website: EntheonBiomedical.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on May 5, 2021.

In this episode of the Psychedelic Spotlight podcast, we speak with Joshua White, who is the Co-Founder and Director of Fireside Project; the first Psychedelic Peer Support Line. Joshua speaks about the creation of Fireside Project and the future of the organization.*To learn more about the company featured in this episode and the work they’re doing, visit their website: FiresideProject.org*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on April 22, 2021.

In this episode of the Psychedelic Spotlight podcast, we speak with the Co-Founder, CEO and Director of Mydecine Innovations Group, Joshua Bartch. We discuss the company's novel research protocols, its relationship with legal psilocybin growers in Jamaica, and the future for psychedelic therapy.*To learn more about the company featured in this episode and the work they’re doing, visit their website: Mydecine.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on April 21, 2021.

In this episode of the Psychedelic Spotlight podcast, we speak with Rabbi Zac Kamenetz, who is the Founder and CEO of Shefa, and the Co-Founder of the Jewish Psychedelic Summit. In our conversation with Rabbi Zac, we discuss the forthcoming Jewish Psychedelic Summit which kicks-off on May 2, 2021, and which, in addition to himself, is being organized by Natalie Ginsberg from MAPS and Madison Margolin from DoubleBlind Magazine. The Summit is scheduled to feature an impressive list of guest speakers highlighted by Rick Doblin. In addition to the Summit, we dive in and explore the connection between Judaism and psychedelics, and how psychedelic therapies may one day bring relief to some of the millions of Jewish people across the globe suffering from the serious effects of trauma. *To register for the Jewish Psychedelic Summit, click HERE. And to learn more about Rabbi Zac and the selfless contributions he is making to the Jewish community through his work, please visit: ShefaFlow.org*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on April 20, 2021.

In this episode of the Psychedelic Spotlight podcast, we connect with Douglas K. Gordon, CEO of Silo Wellness, a wellness company in the psychedelics and functional mushroom marketplace. In our conversation with Douglas, we discuss the company's collaboration with the Bob Marley Estate, and their recent expansion to the Frankfurt Exchange.*To learn more about the company featured in this episode and the work they’re doing, visit their website: SiloWellness.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on April 14, 2021.

Ahead of the PSYCH Investor Summit: Europe and Asia, hosted by Prohibition Partners on April 21, 2021, we sit down with Stephen Murphy, Co-Founder of Prohibition Partners, to discuss investing in the emerging psychedelic industry, and some of the valuable information attendees of the Summit can expect to come away with. Don't miss out on this information-packed event. Register for free today at: PSYCH Investor Summit *Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on April 15, 2021.

In this episode of the Psychedelic Spotlight podcast, we feature Dr. Joseph Tucker, CEO of MagicMed Industries. We talk about MagicMed’s psychedelic library, the company’s plans to go public and what the future of psychedelic research looks like.*To learn more about the company featured in this episode and the work they’re doing, visit their website: MagicMedIndustries.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on March 17, 2021.

In this episode of the Psychedelic Spotlight podcast, we feature Dustin Robinson, Esq. CPA, Founding Partner of Mr. Cannabis Law and Co-Founding Partner of Mr. Psychedelic Law, a Florida-based non-profit organization. In our conversation with Dustin, we cover how he became involved with the medicinal psychedelic space, the advocacy work he is contributing to for psychedelics through Mr. Psychedelic Law, and the recent launch of his venture capital fund, Iter Investments.*To learn more about the company featured in this episode and the work they’re doing, visit their website: MrCannabisLaw.com or MrPsychedelicLaw.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on March 23, 2021.